Press Releases
6 hours ago
Outlook Therapeutics Reports First Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update
Indeterminate
GlobeNewswire, Inc.
6 hours ago
Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026
Indeterminate
GlobeNewswire, Inc.
6 hours ago
Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy
Indeterminate
GlobeNewswire, Inc.
6 hours ago
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
Indeterminate
GlobeNewswire, Inc.
Feb. 12, 2026
Equifruit helps Pattison Food Group elevate banana offering with organic Fairtrade
Indeterminate
GlobeNewswire, Inc.
Feb. 12, 2026
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer
Indeterminate
GlobeNewswire, Inc.
Feb. 12, 2026
Organic Aromas Launches Industry-First Smart Nebulizing Diffuser Line With Bluetooth App Control
Neutral
EIN Presswire
6 hours ago
Kane Biotech Announces FDA 510(k) Clearance for revyve® Antimicrobial Skin and Wound Cleanser
Indeterminate
GlobeNewswire, Inc.
7 hours ago
Why Corporate Wellness Is a Must-Invest Market Now: USD 138.37 Bn Growth Reshaping Workplace Health
Indeterminate
GlobeNewswire, Inc.
Feb. 12, 2026
MTY Food Group Inc Will Hold a Conference Call to Discuss its 2025 Fourth Quarter and Year End Results
Indeterminate
GlobeNewswire, Inc.
7 hours ago
Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with Alkem Laboratories Ltd.
Indeterminate
GlobeNewswire, Inc.